logo
Plus   Neg
Share
Email

XFOR Prices Offering At $12/Shr

X4 Pharmaceuticals, Inc. (XFOR) plans to sell 3.66 million shares of its common stock at $12 per share. The gross proceeds from the offering are expected to be approximately $65.0 million. The offering is slated to close on or about November 29, 2019.

Cowen and Stifel are acting as joint book-running managers for this offering.

Canaccord Genuity and Oppenheimer & Co. are acting as lead managers, and H.C. Wainwright & Co. and Roth Capital Partners are acting as managers for the offering.

X4 Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases.

The lead drug candidate is Mavorixafor.

A pivotal Phase 3 clinical trial of Mavorixafor for the treatment of WHIM syndrome is underway. The 52-week trial is designed to enroll 18 to 28 subjects in
approximately 20 countries, followed by an open-label extension trial.

Mavorixafor is also being explored in other indications like Severe Congenital Neutropenia and advanced clear cell renal cell carcinoma. The Company is also in preparations to begin Phase 1b clinical trial of Mavorixafor in Waldenström's macroglobulinemia later this quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker's revenues topped $100 billion driven by strong demand for latest iPhones and wearables segment. Apple's first-quarter profit rose to $28.76 billion or $1.68 per share from $22.24 billion... Shares of Tesla Motors Inc. (TSLA) slipped 5% in extended trading session on Wednesday after the luxury electric car maker reported a profit for the fourth quarter that fell short of Wall Street analysts' estimates. Palo Alto, California-based Tesla reported fourth-quarter profit of $270 million or... Walmart said it plans to scale the number of stores that will also serve as local fulfillment centers, noting that its customers love the speed and convenience of pickup and delivery. According to the retail giant, dozens of stores will become local fulfilment centers, with many more to come later. A portion of these stores will be converted into automated warehouses.
Follow RTT